What is the pathophysiology, symptoms, diagnosis, management, and differential diagnosis of seborrheic keratosis in a middle-aged to older adult with a history of sun exposure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Seborrheic Keratosis: Clinical Overview

Pathophysiology

Seborrheic keratosis is a benign epidermal keratinocytic tumor resulting from clonal proliferation of keratinocytes, with recent evidence identifying oncogenic mutations (particularly in FGFR3 and PIK3CA pathways) that drive lesion development without risk of malignant transformation. 1, 2

  • The molecular basis involves activating mutations that promote keratinocyte proliferation but lack the invasive potential seen in malignancies 2
  • Age and genetic predisposition are primary drivers, with possible contribution from ultraviolet radiation exposure 1, 2
  • These lesions represent purely benign epithelial proliferations with no malignant potential, distinguishing them fundamentally from premalignant conditions 2

Clinical Presentation

Seborrheic keratoses present as symmetric, "stuck-on," waxy, keratotic papules or plaques with a characteristic verrucous surface, most commonly appearing on the face and upper trunk in middle-aged to elderly patients. 1, 3

  • Lesions typically occur on all body areas except palms and soles, with predilection for sun-exposed sites including face, scalp, and trunk 1
  • Most patients have multiple lesions, with over 10 lesions in the same individual being common 3
  • Lesions are usually asymptomatic but may occasionally be pruritic or tender 4
  • The classic appearance includes a waxy, "stuck-on" quality with well-demarcated borders and variable pigmentation from flesh-colored to dark brown or black 3, 4
  • Multiple clinical subtypes exist based on morphology, including flat, papillomatous, and pedunculated variants 1

Diagnosis

Diagnosis is primarily clinical based on the characteristic stuck-on appearance, but dermoscopy should be employed when diagnostic uncertainty exists, particularly to exclude melanoma or other malignancies. 1, 3

Clinical Diagnosis

  • Visual inspection revealing symmetric, sharply demarcated lesions with waxy or verrucous surface is typically sufficient 1
  • Palpation confirms the "stuck-on" quality that distinguishes SK from other lesions 3

Dermoscopic Features

  • Dermoscopy improves diagnostic accuracy by revealing characteristic patterns including milia-like cysts, comedo-like openings, and fissures/ridges 3, 4
  • Dermoscopy is particularly valuable when lesions mimic melanoma or other skin cancers 3, 4

Histological Confirmation

  • Biopsy is reserved for atypical presentations or when malignancy cannot be excluded clinically 1, 4
  • Histology shows benign keratinocytic proliferation with characteristic features including horn cysts and pseudocysts 1

Critical Pitfall

The major diagnostic challenge is that seborrheic keratoses can mimic melanoma, squamous cell carcinoma, and basal cell carcinoma, while conversely, melanoma can masquerade as seborrheic keratosis—leading to potentially catastrophic delays in cancer diagnosis. 3, 4

Differential Diagnosis

The key differentials requiring exclusion are melanoma, squamous cell carcinoma, and basal cell carcinoma, as misdiagnosis can result in delayed treatment of malignancy. 3, 4

Malignant Differentials (Must Exclude)

  • Melanoma: Can present with similar pigmentation and surface characteristics; dermoscopy and low threshold for biopsy are essential 3, 4
  • Squamous cell carcinoma: May appear similar, particularly with hyperkeratotic SK variants 3
  • Basal cell carcinoma: Can be confused with pigmented SK variants 4

Benign Differentials

  • Actinic keratosis: Distinguished by rough, scaly texture on sun-exposed skin with underlying erythema rather than stuck-on appearance 5, 6
  • Verruca vulgaris: Typically has different distribution and dermoscopic features 4
  • Solar lentigo: Flat macule without raised, stuck-on quality 4

Management

There is no medical indication for treatment of seborrheic keratosis; management is driven entirely by patient cosmetic concerns or symptomatic lesions, with treatment selection based on lesion characteristics and patient preference. 1, 4

Treatment Algorithm

For single or few lesions with cosmetic concerns:

  1. Cryotherapy: First-line option for most lesions; quick, cost-effective 1, 2
  2. Curettage: Effective for thicker lesions; provides tissue for histology if needed 1, 2
  3. Electrocautery: Alternative for resistant lesions 1

For multiple lesions or cosmetically sensitive areas:

  • Ablative laser therapy: Effective with good cosmetic outcomes 2
  • Consider patient tolerance for multiple treatment sessions 1

For patients preferring non-invasive options:

  • Topical 40% hydrogen peroxide: Recently investigated option for non-invasive treatment 2
  • Nitric-zinc complex: Alternative topical therapy under investigation 2

Treatment Considerations

  • All treatments are elective and cosmetic in nature 1, 4
  • Individualize approach based on lesion size, location, number, and patient preference 1
  • Potential side effects include scarring, pigmentary changes, and recurrence 4

Patient Counseling

Patients must understand that seborrheic keratoses are completely benign with zero malignant potential, require no treatment unless desired for cosmetic reasons, and will likely continue to develop new lesions with aging. 1, 2

Key Counseling Points

  • Benign nature: Emphasize these are harmless growths with no cancer risk 1, 2
  • Natural history: New lesions will likely continue to appear with age and sun exposure 1, 2
  • Treatment is optional: No medical necessity for removal; treatment is purely for cosmetic or symptomatic relief 1, 4
  • Monitoring: Patients should report any rapidly changing, bleeding, or painful lesions for re-evaluation to exclude malignancy 4
  • Cost considerations: Treatment is typically cosmetic and may not be covered by insurance 1

Warning Signs Requiring Re-evaluation

  • Rapid growth or change in appearance 4
  • Bleeding or ulceration 4
  • Significant pain or inflammation 4
  • Asymmetry or irregular borders developing 3, 4

References

Research

Seborrheic keratosis.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2023

Research

Differential Diagnosis and Management on Seborrheic Keratosis in Elderly Patients.

Clinical, cosmetic and investigational dermatology, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Actinic Keratosis: Clinical Overview and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.